Evidence map›Paper›PMID 28813512›Full record

Trial reportPloS one2017

Implementation of a comprehensive intervention for patients at high risk of cardiovascular disease in rural China: A pragmatic cluster randomized controlled trial.

Xiaolin Wei, John D Walley, Zhitong Zhang, Guanyang Zou, Weiwei Gong, Simin Deng, Anthony D Harries, Joseph P Hicks, Marc K C Chong, James N Newell and 2 more

Open access · goldAbstract readRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 4 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 4 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 5 countries.

Xiaolin WeiDivision of Clinical Public Health and Institute of Health Policy Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.ORCID http://orcid.org/0000-0002-3076-2650
John D WalleyNuffield Centre for International Health and Development, University of Leeds, Leeds, United Kingdom.
Zhitong ZhangChina Global Health Research and Development, Shenzhen, China.
Guanyang ZouChina Global Health Research and Development, Shenzhen, China.
Weiwei GongZhejiang Centre for Disease Control and Prevention, Hangzhou, China.
Simin DengChina Global Health Research and Development, Shenzhen, China.
Anthony D HarriesInternational Union against Tuberculosis and Lung Disease, Paris, France and London School of Hygiene and Tropical Medicine, London, United Kingdom.
Joseph P HicksNuffield Centre for International Health and Development, University of Leeds, Leeds, United Kingdom.
Marc K C ChongSchool of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, China.
James N NewellNuffield Centre for International Health and Development, University of Leeds, Leeds, United Kingdom.
Jieming ZhongZhejiang Centre for Disease Control and Prevention, Hangzhou, China.
Min YuZhejiang Centre for Disease Control and Prevention, Hangzhou, China.
University of Leeds · GBZhejiang Center for Disease Control and Prevention · CNChinese University of Hong Kong · HKLondon School of Hygiene & Tropical Medicine · GBUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aims to assess whether a standard intervention package of cardiovascular disease (CVD) care was being delivered effectively, and if it was associated with improved lifestyle and biomedical indicators.

methodsIn rural China, we implemented a pragmatic cluster randomized controlled trial for 12 months, randomized at the township hospital level, and compared with usual care. Intervention case management guideline, training and performance monitoring meeting and patient support activities were designed to fit within the job description of family doctors in the township hospitals and comprised: 1) prescription of a standardised package of medicines targeted at those with hypertension or diabetes; 2) advice about specific lifestyle interventions; and 3) advice about medication adherence. Participants were 50-74 years old, had hypertension and CVD risk scores >20% or diabetes, but were excluded if a history of severe CVD events. We also randomly selected 100 participants from six selected clusters per arm as a panel to collect intermediate biomedical indicators over time.

resultsA total of 28,130 participants, in 33 intervention and 34 control township hospitals, were recruited. Compared with the control arm, participants in the intervention arm had substantially improved prescribing rates of anti-hypertensives, statins and aspirin (P<0.001), and had higher medication taking rates of aspirin and statins (P<0.001). Mean systolic and diastolic blood pressures were similar across both arms (0.15 mmHg, P = 0.79, and 0.52 mmHg, P = 0.05, respectively). In the panel, (950) rates of smoking (OR = 0.23, P = 0.02) and salt intake (OR = 2.85, P = 0.03) were significantly reduced in the intervention versus control arms, but there were no statistically significant improvement over the 12 month follow-up period in biomedical indicators (P>0.05).

conclusionImplementation of the package by family doctors was feasible and improved prescribing and some lifestyle changes. Additional measures such as reducing medication costs and patient education are required.

trial registrationCurrent Controlled Trials ISRCTN58988083.

Indexed as

AgedAntihypertensive AgentsBlood PressureCardiovascular DiseasesChinaDiabetes MellitusFemaleHumansHypertensionMaleMedication AdherenceMiddle AgedAntihypertensive Agents

Identifiers

PMID28813512
PMCPMC5559073
OpenAlexW2745427180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.